Home Nephtimes Conferences

Conferences

Proton Pump Inhibitor Use Associated with Metabolic Acidosis and CKD

Autosomal dominant polycystic kidney disease (ADPKD)

Tolvaptan for ADPKD: Two-Years of Follow-up

Diabetes Screening

Phase 1b Study of DM199 in Patients with Diabetes and CKD

Anemia

Long-acting Anemia Treatment May Stabilize Hemoglobin Levels

Worsened Outcomes Associated with Anemia in CKD

CKD

Cochrane review and Meta-Analysis of Potassium Binders for Hyperkalemia

EMERALD: Patiromer for Hyperkalemia Treatment in Pediatric CKD

kidney

Metabolic Acidosis in Patients with CKD and Hyperkalemia

Not Enough Cancer Patients Enroll in Potentially Life-Extending Clinical Trials

Ongoing Prospective Study of Outcomes of Metabolic Acidosis: ULTIMA-CKD

kidney injury

Metabolic Acidosis Predicts All-Cause Mortality in CKD Patients

Load more
Subscribe to RSS
Advertisement

#Trending in